Vutrisiran is already approved as Amvuttra to treat polyneuropathy caused by ATTR, but extending its indications to include ...

Welcome back to Changing Faces for the month of July. We’re trying something new this month. Rather than consigning the many ...

Since the turn of the decade, the pharmaceuticals industry has dealt with supply chain challenges caused by both the pandemic ...

Emergent BioSolutions has been given FDA approval to extend the indications for its smallpox vaccine ACAM2000 to include the ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 ...

Social determinants of health (SDOH) – including housing, health literacy, transportation, and social support – can ...

The trial recruited patients who were not on lipid-lowering therapy, so a group with a lower risk of developing ASCVD than is ...

Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was ...

ReNeuron is the latest in a lengthening list of UK biotechs saying that it is too challenging to raise capital on the AIM and ...

The news comes just days after BioMarin also announced a major change to its senior leadership team aimed at boosting its ...

The European Commission has approved SIFI's Akantior as the first therapy anywhere in the world for acanthamoeba keratitis ...

Johnson & Johnson has submitted its first marketing application for nipocalimab, seeking approval for the FcRn blocker in ...